Forecast & Rating2 analysts currently cover Lexaria Bioscience, of which 1 give a positive rating. The average price target is $52.50, about 373.1% upside from the current price of $11.10. Coverage is limited, so the data is for reference only. Data as of Aug 3, 2026; this does not constitute investment advice.
Jul 17, 2026Price forecast
$52.50373.06%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met6.9%
Stock price$11.10
Avg. target$52.5
High target$82
Low target$22
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.